InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Sanjay Chanda, Chief Development Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 3 open-market SEC Form 4 transactions: 0 purchases worth $0 and 3 sales worth $13K, reported from Jan 3, 25 to Jan 6, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 6, 26 | ANTXAN2 Therapeutics, Inc. | SELL | 6.0K | $1.01 | $6K |
| Jan 5, 26 | ANTXAN2 Therapeutics, Inc. | SELL | 3.3K | $1.00 | $3K |
| Jan 3, 25 | ANTXAN2 Therapeutics, Inc. | SELL | 3.0K | $1.34 | $4K |